logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Hospital Center University De Lille

+33320445962
soutenir@chu-lille.fr
Source: Site record.
https://www.chu-lille.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Lille University Hospital (CHU de Lille) is one of the largest healthcare campuses in Northern Europe. As a university hospital dedicated to prevention, patient care ranging from local healthcare services to the treatment of highly complex conditions, education, and research, it provides patients with innovative care through state-of-the-art medical and technical facilities and specialized medical expertise.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
64Total Trials
Source: Trial-derived.
15Recruiting Trials
Source: Trial-derived.
34Active Trials
Source: Trial-derived.
24Completed Trials
Source: Trial-derived.
119Unique Conditions
Source: Trial-derived.
95Unique Sponsors

Conditions

Source: Trial-derived. Melanoma (3)Source: Trial-derived. COVID (2)Source: Trial-derived. Hypertension (2)Source: Trial-derived. Parkinson Disease (2)Source: Trial-derived. Acute Coronary Syndrome (1)Source: Trial-derived. Acute Febrile Illness (1)Source: Trial-derived. Acute Lymphoblastic Leukemia (1)Source: Trial-derived. Acute Myeloblastic Leukemia Core Binding Factor (1)

Sponsors

Source: Trial-derived. University Hospital, Lille (10)Source: Trial-derived. Central Hospital, Nancy, France (4)Source: Trial-derived. Ministry of Health, France (4)Source: Trial-derived. University Hospital, Tours (4)Source: Trial-derived. Nantes University Hospital (3)Source: Trial-derived. Regeneron Pharmaceuticals (3)Source: Trial-derived. University Hospital, Strasbourg, France (3)Source: Trial-derived. Amsterdam UMC (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 T-cell enumeration
Source: AI-inferred. Complex endovascular aortic repair (fenestrated stent-graft implantation)
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Interactive voice response system
Source: AI-inferred. Intravesical drug administration
Source: AI-inferred. Intravesical drug-delivery device insertion and removal
Source: AI-inferred. Transurethral resection of bladder tumour (TURBT)